openPR Logo
Press release

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033

03-14-2024 06:50 AM CET | Health & Medicine

Press release from: The Business research company

Chemotherapy Induced Peripheral Neuropathy Treatment Market

Chemotherapy Induced Peripheral Neuropathy Treatment Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The chemotherapy induced peripheral neuropathy treatment market size has grown strongly in recent years. It will grow from $1.54 billion in 2023 to $1.65 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to chemotherapy advancements, cancer treatment expansion, limited treatment options, increased cancer incidences, neurological research.

The chemotherapy induced peripheral neuropathy treatment market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to targeted therapies development, neuroprotective agents, integrated care pathways, patient-centered care models, regulatory support. Major trends in the forecast period include novel drug formulations, non-pharmacological interventions, neuroplasticity-based therapies, long-term survivorship support, cognitive behavioral therapies.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11967&type=smp

Market Segmentation:
The chemotherapy induced peripheral neuropathy treatment market covered in this report is segmented -
1) By Drug Class: Nerve Protective Therapy, Anti-Inflammatory Therapy, Neurotransmitter Based Therapy, Antioxidant, Other Drug Classes
2) By Treatment: Medication, Therapy, Other Treatments
3) By Drug Type: Branded, Generic
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels
5) By End-User: Hospitals, Research Institutes, Specialty Clinics

Major Driver - Rising Cancer Prevalence Boosts Chemotherapy-Induced Peripheral Neuropathy Treatment Market
The increasing prevalence of cancer is expected to propel the growth of the chemotherapy-induced peripheral neuropathy treatment market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. Chemotherapy-induced peripheral neuropathy is a potential side effect of certain chemotherapy drugs used in the treatment of cancer. The chemotherapy-induced peripheral neuropathy treatment market is subjected to grow as there is a rise of cancer cases globally. For instance, in January 2023, according to the report published by the American Cancer Society, a US-based nationwide voluntary health organization dedicated to eliminating cancer, estimated new cases of liver cancer in females diagnosed in the United States increased from 12,660 in 2022 to 13,230 in 2023. Therefore, the increasing prevalence of cancers driving the growth of the chemotherapy-induced peripheral neuropathy treatment market.

Competitive Landscape:
Major companies operating in the chemotherapy induced peripheral neuropathy treatment market report are Sanofi SA, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical Company, Amgen Inc., Asahi Kasei Pharma Corporation, Toray Industries , Vertex Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., BioMérieux SA, Jazz Pharmaceuticals Inc., WEX Pharmaceuticals Inc., Quidel Corporation, Laboratories Dr. Esteve S.A. (ESTEVE), Genentech Inc., MediciNova Inc., ChromaDex Corp, WinSanTor Inc., Solasia Pharma K.K., NeuroMetrix Inc., Nemus Bioscience Inc., Aphios Corporation, Kineta Inc., DARA BioSciences Inc., Aptinyx Inc., Apexian Pharmaceuticals Inc., Krenitsky Pharmaceuticals Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Top Trend - Innovation In Chemotherapy-Induced Peripheral Neuropathy Treatment Market
Product Innovation is the key trend gaining popularity in the chemotherapy-induced peripheral neuropathy treatment market. Major companies involved in the chemotherapy-induced peripheral neuropathy treatment market are focused on innovating new products to improve their observation power and sustain their position in the market. For instance, in March 2023, AlgoTx, a clinical-stage company specializing in complex pain management, disclosed the FDA's approval of the Investigational New Drug Application (IND) for ATX01, their Phase 2 first-in-class candidate. This innovative treatment is intended for individuals with erythromelalgia. Meanwhile, the first patients in the ATX01 for the Pain of Chemotherapy (ACT) study of chemotherapy-induced peripheral neuropathy (CIPN) have been randomized. The FDA has given both programs fast-track designation.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chemotherapy Induced Peripheral Neuropathy Treatment Market Characteristics
3. Chemotherapy Induced Peripheral Neuropathy Treatment Market Trends And Strategies
4. Chemotherapy Induced Peripheral Neuropathy Treatment Market - Macro Economic Scenario
5. Chemotherapy Induced Peripheral Neuropathy Treatment Market Size And Growth
…..
27. Chemotherapy Induced Peripheral Neuropathy Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 here

News-ID: 3428745 • Views:

More Releases from The Business research company

Steady Expansion Forecast for Cloud Manufacturing Market, Projected to Reach $193 Billion by 2029
Steady Expansion Forecast for Cloud Manufacturing Market, Projected to Reach $19 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cloud Manufacturing Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the past few years, the cloud manufacturing market's dimensions have expanded at a swift pace. It is expected to surge from $85.88 billion in 2024 to $100.34 billion in 2025, reflecting a compound annual
Call Center Outsourcing Market Expansion Continues, with Forecast Valuation of $160.74 Billion by 2029
Call Center Outsourcing Market Expansion Continues, with Forecast Valuation of $ …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Call Center Outsourcing Market Size Growth Forecast: What to Expect by 2025? The size of the call center outsourcing market has witnessed substantial growth in the past few years. The market, valued at $113.49 billion in 2024, is projected to increase to $120.26 billion in 2025, representing a compound
Key Factor Supporting Global Cloud Data Security Market Development in 2025: Rise In Cyber Data Theft Propels Growth Of Cloud Data Security Market
Key Factor Supporting Global Cloud Data Security Market Development in 2025: Ris …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cloud Data Security Market Size By 2025? In recent years, the size of the cloud data security market has seen a substantial expansion. The market, currently valued at $6.02 billion in 2024, is projected to increase to $6.73 billion by 2025, which represents a compound
The Growing Impact of Cyber Attacks On The Bot Security Market: The Driving Engine Behind Bot Security Market Evolution in 2025
The Growing Impact of Cyber Attacks On The Bot Security Market: The Driving Engi …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Bot Security Industry Market Size Be by 2025? The market size of bot security has experienced a significant expansion in the past few years. This segment is projected to experience a rise from $0.75 billion in 2024 to $0.89 billion in 2025, with a compounded annual

All 5 Releases


More Releases for Chemotherapy

Chemotherapy Devices Market - Innovation for Life: Chemotherapy Devices Driving …
Newark, New Castle, USA: The "Chemotherapy Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Chemotherapy Devices Market: https://www.growthplusreports.com/report/chemotherapy-devices-market/8623 This latest report researches the industry structure, sales, revenue,
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications. Chemotherapy can be taken as pills or as injections. You may visit a clinic
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine 1.1 Overview 1.2 Nano Chemotherapeutics with Pharmaceutical Potential Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations 2.1 Limitations of Conventional Chemotherapy 2.2 Nanotechnology in Cancer Targeting 2.2.1 Active Targeting 2.2.2 Passive Targeting 2.2.3 pH Dependent Drug Delivery Through Nanoparticles Role
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics. For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Download Report: